These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 21154140)

  • 1. MicroRNA dysregulation in cancer: opportunities for the development of microRNA-based drugs.
    Nana-Sinkam SP; Croce CM
    IDrugs; 2010 Dec; 13(12):843-6. PubMed ID: 21154140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNAs as biomarkers and therapeutic targets in cancer.
    Heneghan HM; Miller N; Kerin MJ
    Curr Opin Pharmacol; 2010 Oct; 10(5):543-50. PubMed ID: 20541466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies.
    Wei J; Xie L; Taron M; Rosell R; Liu B
    Drug News Perspect; 2010 Dec; 23(10):655-61. PubMed ID: 21180651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.
    Cho WC
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1273-81. PubMed ID: 20026422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases.
    Wang Y; Liang Y; Lu Q
    Clin Genet; 2008 Oct; 74(4):307-15. PubMed ID: 18713257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA and drug resistance.
    Ma J; Dong C; Ji C
    Cancer Gene Ther; 2010 Aug; 17(8):523-31. PubMed ID: 20467450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of microRNAs to Cancer Therapy].
    Iguchi H; Ochiya T
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):389-95. PubMed ID: 20332672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting the therapeutic potential of microRNAs in human cancer.
    Cho WC
    Expert Opin Ther Targets; 2012 Apr; 16(4):345-50. PubMed ID: 22339340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs and future therapeutic applications in cancer.
    Casalini P; Iorio MV
    J BUON; 2009 Sep; 14 Suppl 1():S17-22. PubMed ID: 19785062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of microRNA in cancer and apoptosis.
    Lynam-Lennon N; Maher SG; Reynolds JV
    Biol Rev Camb Philos Soc; 2009 Feb; 84(1):55-71. PubMed ID: 19046400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer therapy via modulation of micro RNA levels: a promising future.
    Kota SK; Balasubramanian S
    Drug Discov Today; 2010 Sep; 15(17-18):733-40. PubMed ID: 20692360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential microRNA therapies targeting Ras, NFkappaB and p53 signaling.
    Kasinski AL; Slack FJ
    Curr Opin Mol Ther; 2010 Apr; 12(2):147-57. PubMed ID: 20373258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in cancer management and their modulation by dietary agents.
    Karius T; Schnekenburger M; Dicato M; Diederich M
    Biochem Pharmacol; 2012 Jun; 83(12):1591-601. PubMed ID: 22342289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression and function in cancer.
    Garzon R; Fabbri M; Cimmino A; Calin GA; Croce CM
    Trends Mol Med; 2006 Dec; 12(12):580-7. PubMed ID: 17071139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of LNA in microRNA-based cancer diagnostics and therapeutics.
    Stenvang J; Silahtaroglu AN; Lindow M; Elmen J; Kauppinen S
    Semin Cancer Biol; 2008 Apr; 18(2):89-102. PubMed ID: 18295505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA in colorectal cancer: from benchtop to bedside.
    Wu WK; Law PT; Lee CW; Cho CH; Fan D; Wu K; Yu J; Sung JJ
    Carcinogenesis; 2011 Mar; 32(3):247-53. PubMed ID: 21081475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
    Hummel R; Hussey DJ; Haier J
    Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?
    Weiler J; Hunziker J; Hall J
    Gene Ther; 2006 Mar; 13(6):496-502. PubMed ID: 16195701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA dysregulation in gastric cancer: a new player enters the game.
    Wu WK; Lee CW; Cho CH; Fan D; Wu K; Yu J; Sung JJ
    Oncogene; 2010 Oct; 29(43):5761-71. PubMed ID: 20802530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Not miR-ly small RNAs: big potential for microRNAs in therapy.
    Love TM; Moffett HF; Novina CD
    J Allergy Clin Immunol; 2008 Feb; 121(2):309-19. PubMed ID: 18269923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.